SFP
ONCS

Sandbox Financial Partners’s OncoSec Medical Incorporated ONCS Stock Holding History

Sandbox Financial Partners’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,136
Closed -$12K – 95
2022
Q3 		$12K Hold
1,136
– – 0.01% 83
2022
Q2 		$19K Sell
1,136
-114
-9% -$2.19K 0.01% 86
2022
Q1 		$32K Sell
1,250
-1,591
-56% -$33.6K 0.02% 94
2021
Q4 		$60K Buy
2,841
+1,705
+150% +$57.6K 0.04% 99
2021
Q3 		$53K Buy
+1,136
New +$57.5K 0.04% 91
2021
Q1 		– Sell
-3,409
Closed -$484K – 94
2020
Q4 		$484K Buy
+3,409
New +$364K 0.44% 31

Other funds holding ONCS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sandbox Financial Partners's ONCS Position: Q4 2022 in Review

Sandbox Financial Partners sold out of OncoSec Medical Incorporated (ONCS) in Q4 2022, closing a stake of 1,136 shares — an estimated $12K sold.

Sandbox Financial Partners first reported a position in ONCS in Q4 2020 and held it in 6 quarters. The position peaked at $484K in Q4 2020. 17 funds tracked by Wall St. Rank hold ONCS as of Q4 2022.

  • Sandbox Financial Partners reported no remaining OncoSec Medical Incorporated position as of Q4 2022 after selling out during the quarter.
  • Sandbox Financial Partners sold 1,136 OncoSec Medical Incorporated shares in Q4 2022, an estimated $12K.
  • Sandbox Financial Partners first reported a position in OncoSec Medical Incorporated in Q4 2020 and held it in 6 quarters.
  • Sandbox Financial Partners's OncoSec Medical Incorporated position peaked at $484K in Q4 2020.
  • 17 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2022.

Based on Sandbox Financial Partners's 13F filing for Q4 2022, filed 25 Jan 2023.